E-LIB Suche - Ergebnisse für: Nauck, Michael A.

1

Getting the measure of the pressure: Optimal assessment of ..:

Jones, Karen L. ; Marathe, Chinmay S. ; Wu, Tongzhi...
Diabetes, Obesity and Metabolism. , 2024

Link: https://doi.org/10.1111/..

2

Comparison of tirzepatide and dulaglutide on major adverse ..:

Nicholls, Stephen J. ; Bhatt, Deepak L ; Buse, John B...
American Heart Journal. 267 (2024) - p. 1-11 , 2024

Link: https://doi.org/10.1016/..

3

CVOT Summit 2022 Report: new cardiovascular, kidney, and gl..:

Schnell, Oliver ; Battelino, Tadej ; Bergenstal, Richard...
Cardiovascular Diabetology. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

4

Non-peptide, once-per-day oral orforglipron to compete with..:

Nauck, Michael A ; Horowitz, Michael
The Lancet. 402 (2023) 10400 - p. 429-431 , 2023

Link: https://doi.org/10.1016/..

5

Comparison of Insulin-Treated Patients with Ambiguous Diabe..:

Laspe, Insa ; Meier, Juris J. ; Nauck, Michael A.
Diabetes & Metabolism Journal. 47 (2023) 1 - p. 140-146 , 2023

Link: https://doi.org/10.4093/..

6

Incretin hormones and type 2 diabetes:

Nauck, Michael A. ; Müller, Timo D.
Diabetologia. 66 (2023) 10 - p. 1780-1795 , 2023

Link: https://doi.org/10.1007/..

7

Meta‐analysis of head‐to‐head clinical trials comparing inc..:

Nauck, Michael A. ; Mirna, Abd El Aziz ; Quast, Daniel R.
Diabetes, Obesity and Metabolism. 25 (2023) 5 - p. 1361-1371 , 2023

Link: https://doi.org/10.1111/..

8

Effects of Initial Combinations of Gemigliptin Plus Metform..:

Lim, Soo ; Sohn, Minji ; Florez, Jose C...
Nutrients. 15 (2023) 1 - p. 248 , 2023

Link: https://doi.org/10.3390/..

9

Impact of concomitant oral glucose-lowering medications on ..:

Wollenhaupt, Dominik ; Wolters, Jannik ; Abd El Aziz, Mirna.
BMJ Open Diabetes Research & Care. 11 (2023) 4 - p. e003296 , 2023

Link: https://doi.org/10.1136/..

10

GIP und GLP-1-Rezeptoragonismus in der Therapie des Typ 2 D..:

Nauck, Michael A. ; Blüher, Matthias ; Meyhöfer, Sebastian M...
Diabetologie und Stoffwechsel. 18 (2023) 6 - p. 475-487 , 2023

Link: https://doi.org/10.1055/..

11

Characteristics predicting the efficacy of SGLT-2 inhibitor..:

Sohn, Minji ; Dietrich, Johannes W. ; Nauck, Michael A..
Cardiovascular Diabetology. 22 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

12

Gut hormone co-agonists for the treatment of obesity: from ..:

Nogueiras, Ruben ; Nauck, Michael A. ; Tschöp, Matthias H.
Nature Metabolism. 5 (2023) 6 - p. 933-944 , 2023

Link: https://doi.org/10.1038/..

13

Charakterisierung der Blutzucker-Einstellungsqualität unte..:

Gerken, Sonja Dorothea Claudia , 2022

Link: https://nbn-resolving.de..

14

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the t..:

Nauck, Michael A. ; D'Alessio, David A.
Cardiovascular Diabetology. 21 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

15

Statistical power for MACE and individual secondary endpoin..:

Birker, Sebastian ; Meier, Juris J. ; Nauck, Michael A.
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..